Delivery Order SPE2DB22D3301-SPE2DB25FY2PU
Award Date
4/2/25
Potential Completion Date
4/3/25
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $44,430.73, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for 4,566,211,113 tablets of the medication Meloxicam 15 mg, with a firm fixed price and an ultimate completion date of October 28, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $6,517.45 and covers the delivery of 4,566,709,125 units of the medication Meloxicam 15 mg tablets. The contract is a Firm Fixed Price Delivery Order with a performance period through December 13, 2024. This award is part of a larger $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,269.10, is for the delivery of 180 tablets of the medication Meloxicam 15 mg. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of June 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This federal contract award, valued at $6,335.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,303,713 units of Meloxicam 15 mg tablets, a medication used to treat pain and inflammation. The contract has an ultimate completion date of February 19, 2025 and is a Firm Fixed Price Delivery Order. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,658.57 firm fixed-price delivery order is for the supply of 4,566,626,138 units of the generic medication Meloxicam 15 mg tablets. The contract has an ultimate completion date of December 6, 2024 and was awarded on December 5, 2024. This award appears to be part of a larger...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Meloxicam 7.5 mg tablets, a non-steroidal anti-inflammatory drug, with a ceiling value of $26,522.01. It is a firm fixed-price delivery order contract with a period of performance through September 23, 2024. AmerisourceBergen is a large supplier of pharmaceutical and medical products to various...
This federal contract award, identified as SPE2DX15D3005|SPE2DX25F3MQX, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp. The contract, valued at $17,697.34, is for the delivery of 4,566,307,554 units of Meloxicam 15 mg tablets. It is a firm fixed-price delivery order contract with a period of performance through November 4, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
This federal contract award, with ID SPE2DB22D3004|SPE2DB24FPH40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $45,412.58, is for the delivery of meloxicam 15 mg tablets. It is a firm fixed-price delivery order contract with a completion date of February 14, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
This federal contract award is for the delivery of 4,566,281,392 units of 15 mg Meloxicam tablets over a period ending on October 31, 2024. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $39,305.93. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $46,876.90, is for the delivery of 4,566,770,568 units of Meloxicam 15 mg tablets. The contract has an ultimate completion date of December 20, 2024 and is a firm fixed-price agreement. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...